Davidson, M. B., Navar, M. D., Echeverry, D., & Duran, P. (2010). U-500 Regular Insulin: Clinical experience and pharmacokinetics in obese, severely insulin-resistant type 2 diabetic patients. American Diabetes Association.
Chicago-stil citatDavidson, Mayer B., Maria D. Navar, Diana Echeverry, och Petra Duran. U-500 Regular Insulin: Clinical Experience and Pharmacokinetics in Obese, Severely Insulin-resistant Type 2 Diabetic Patients. American Diabetes Association, 2010.
MLA-referensDavidson, Mayer B., Maria D. Navar, Diana Echeverry, och Petra Duran. U-500 Regular Insulin: Clinical Experience and Pharmacokinetics in Obese, Severely Insulin-resistant Type 2 Diabetic Patients. American Diabetes Association, 2010.
Varning: dessa hänvisningar är inte alltid fullständigt riktiga.